Advertisement

Endocrine

, Volume 36, Issue 2, pp 255–261 | Cite as

Methyltetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy

  • Kubilay Ukinc
  • Halil Onder Ersoz
  • Caner Karahan
  • Cihangir Erem
  • Selcuk Eminagaoglu
  • Arif Bayram Hacihasanoglu
  • Mustafa Yilmaz
  • Mustafa Kocak
Original Paper

Abstract

Hyperhomocysteinemia is a well-defined risk factor for endothelial dysfunction and atherosclerosis. A point mutation (677 C-T) of MTHFR gene results in a significant increase at plasma homocysteine levels. In this study we aimed to evaluate the effects of MTHFR gene mutation and consequent hyperhomocysteinemia on the development of diabetic microvascular complications in comparison with the other defined risk factors. Diabetic patients without a history of macrovascular complication or overt nephropathy enrolled into the study. The presence of MTHFR 677 C-T point mutation was evaluated by Real-Time PCR technique by using a LightCycler. MTHFR heterozygous mutation was present in 24 patients over 52. Patients with diabetes were divided into two groups according to the presence of MTHFR gene mutation. Both groups were well matched regarding age and diabetes duration. Metabolic parameters, plasma homocysteine, microalbuminuria, folic acid, and vitamin B12 levels were also studied. Presence of neuropathy and retinopathy were evaluated by specific tests. Duration of diabetes, BMI, systolic and diastolic blood pressure, plasma CRP, HbA1c, and lipid levels were not different between the two groups. Plasma homocysteine (12.89 ± 1.74 and 8.98 ± 1.91 μmol/l; P < 0.0001) and microalbuminuria levels (73.40 ± 98.15 and 29.53 ± 5.08 mg/day; P = 0.021) were significantly higher in the group with MTHFR gene mutation while creatinine clearance levels (101.1 ± 42.6 and 136.21 ± 51.50 ml/min; P = 0.008) were significantly lower. Sixteen over 22 (73%) of the patients with diabetic nephropathy had MTHFR gene mutation, while this was only 27% (8 over 30) in normoalbuminuric patients (P = 0.017). There was a significant correlation of plasma homocysteine level with microalbuminuria (r = 0.54; P = 0.031) in the patients with diabetic nephropathy who had C677T polymorphism. We did not find any specific association of MTHFR gene mutation and hyperhomocysteinemia with retinopathy or neuropathy.

Keywords

MTHFR C677T mutation Type 2 diabetes Hyperhomocysteinemia Diabetic nephropathy 

References

  1. 1.
    American Diabetes Association, Standards of medical care in diabetes—2008. Diabetes Care 31(Suppl 1), S12–S54 (2008)CrossRefGoogle Scholar
  2. 2.
    M.A. Gall, P. Hougaard, K. Borch-Johnsen, H.H. Parving, BMJ 314, 783–788 (1997)PubMedGoogle Scholar
  3. 3.
    M. Ravid, R. Lang, R. Rachmani, M. Lishner, Arch. Intern. Med. 156, 286–289 (1996)CrossRefPubMedGoogle Scholar
  4. 4.
    A. Doria, Horm. Res. 50(Suppl 1), 6–11 (1998)CrossRefPubMedGoogle Scholar
  5. 5.
    S. Fava, A.T. Hattersley, Nephrol. Dial. Transplant. 17, 1543–1546 (2002)CrossRefPubMedGoogle Scholar
  6. 6.
    S. Schmidt, E. Ritz, Kidney Int. Suppl. 63, S27–S31 (1997)PubMedGoogle Scholar
  7. 7.
    K. Borch-Johnsen, K. Norgaard, E. Hommel, E.R. Mathiesen, J.S. Jensen, T. Deckert, H.H. Parving, Kidney Int. 41, 719–722 (1992)CrossRefPubMedGoogle Scholar
  8. 8.
    V. Shpichinetsky, I. Raz, Y. Friedlander, N. Goldschmidt, I.D. Wexler, A. Ben-Yehuda, G. Friedman, J. Nutr. 130, 2493–2497 (2000)PubMedGoogle Scholar
  9. 9.
    J.D. Finkelstein, J.J. Martin, Int. J. Biochem. Cell Biol. 32, 385–389 (2000)CrossRefPubMedGoogle Scholar
  10. 10.
    P. Ksiazek, A. Bednarek-Skublewska, M. Buraczynska, Med. Sci. Monit. 10, BR47–BR51 (2004)PubMedGoogle Scholar
  11. 11.
    D. Moczulski, H. Fojcik, E. Zukowska-Szczechowska, I. Szydlowska, W. Grzeszczak, Nephrol. Dial. Transplant. 18, 1535–1540 (2003)CrossRefPubMedGoogle Scholar
  12. 12.
    P. Frosst, H.J. Blom, R. Milos, P. Goyette, C.A. Sheppard, R.G. Matthews, G.J. Boers, M. den Heijer, L.A. Kluijtmans, L.P. van den Heuvel, Nat. Genet. 10, 111–113 (1995)CrossRefPubMedGoogle Scholar
  13. 13.
    P.F. Jacques, A.G. Bostom, R.R. Williams, R.C. Ellison, J.H. Eckfeldt, I.H. Rosenberg, J. Selhub, R. Rozen, Circulation 93, 7–9 (1996)PubMedGoogle Scholar
  14. 14.
    S.S. Kang, J. Zhou, P.W. Wong, J. Kowalisyn, G. Strokosch, Am. J. Hum. Genet. 43, 414–421 (1988)PubMedGoogle Scholar
  15. 15.
    H. Fujita, T. Narita, H. Meguro, T. Ishii, O. Hanyu, K. Suzuki, K. Kamoi, S. Ito, J. Diabetes Complications 13, 284–287 (1999)CrossRefPubMedGoogle Scholar
  16. 16.
    S. Neugebauer, T. Baba, T. Watanabe, Lancet 352, 454 (1998)CrossRefPubMedGoogle Scholar
  17. 17.
    V. Fonseca, S.C. Guba, L.M. Fink, Endocr. Rev. 20, 738–759 (1999)CrossRefPubMedGoogle Scholar
  18. 18.
    H. Blackburn, A. Keys, E. Simonson, P. Rautaharju, S. Punsar, Circulation 21, 1160–1175 (1960)PubMedGoogle Scholar
  19. 19.
    D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Diabetologia 28, 412–419 (1985)CrossRefPubMedGoogle Scholar
  20. 20.
    S.A. Miller, D.D. Dykes, H.F. Polesky, Nucleic Acids Res. 16, 1215 (1988)CrossRefPubMedGoogle Scholar
  21. 21.
    N.B. Tutuncu, T. Erbas, M. Alikasifoglu, E. Tuncbilek, J. Intern. Med. 257, 446–453 (2005)CrossRefPubMedGoogle Scholar
  22. 22.
    L. Brattstrom, D.E. Wilcken, J. Ohrvik, L. Brudin, Circulation 98, 2520–2526 (1998)PubMedGoogle Scholar
  23. 23.
    O. Vaccaro, A.F. Perna, F.P. Mancini, V. Cuomo, M. Sacco, A. Tufano, A.A. Rivellese, D. Ingrosso, G. Riccardi, Diabetes Care 23, 1026–1027 (2000)CrossRefPubMedGoogle Scholar
  24. 24.
    J.W. Foreman, H. Wald, G. Blumberg, L.M. Pepe, S. Segal, Metabolism 31, 613–619 (1982)CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Kubilay Ukinc
    • 1
  • Halil Onder Ersoz
    • 2
  • Caner Karahan
    • 3
  • Cihangir Erem
    • 2
  • Selcuk Eminagaoglu
    • 3
  • Arif Bayram Hacihasanoglu
    • 2
  • Mustafa Yilmaz
    • 4
  • Mustafa Kocak
    • 2
  1. 1.Çanakkale Onsekiz Mart Universitesi, Tıp Fakultesi, Endokrinoloji ve Metabolizma Hastaliklari BDÇanakkaleTurkey
  2. 2.Department of Endocrinology and MetabolismKaradeniz Technical UniversityTrabzonTurkey
  3. 3.Department of BiochemistryKaradeniz Technical UniversityTrabzonTurkey
  4. 4.Department of HematologyKaradeniz Technical UniversityTrabzonTurkey

Personalised recommendations